The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity

por Hamed, Eman Mostafa, Ibrahim, Ahmed R. N., Meabed, Mohamed Hussein, Khalaf, Ahmed M., El Demerdash, Doaa Mohamed, Elgendy, Marwa O., Saeed, Haitham, Salem, Heba F., Rabea, Hoda
Publicado 2023

Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relap...

por Hamed, Eman Mostafa, Ibrahim, Ahmed R. N., Meabed, Mohamed Hussein, Khalaf, Ahmed M., El Demerdash, Doaa Mohamed, Elgendy, Marwa O., Saeed, Haitham, Salem, Heba F., Rabea, Hoda
Publicado 2023

Clinical Care Team’s Guide for Awareness on Risk Assessment of Eltrombopag Complicating Acute Kidney Injury in Relapsed Immune Thrombocytopenic Patients: A Case Report

por Hamed, Eman Mostafa, Meabed, Mohamed Hussein, Ibrahim, Ahmed R. N., Khalaf, Ahmed M., El Demerdash, Doaa Mohamed, Elgendy, Marwa O., Saeed, Haitham, Mahmoud, Tamer M., Salem, Heba F., Rabea, Hoda
Publicado 2023